Lupin informs about press release

30 Apr 2020 Evaluate

Lupin has informed that it has enclosed a Press Release on 30th April 2020 as regards receipt of Establishment Inspection Report from the US FDA for the Company’s Pithampur Unit-1, India facility. Inspection for the said facility was conducted by the US FDA between February 3, 2020 and February 11, 2020 and concluded with two observations.

The above information is a part of company’s filings submitted to BSE. 

Lupin Share Price

2118.25 5.10 (0.24%)
18-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1745.35
Dr. Reddys Lab 1279.60
Cipla 1499.10
Zydus Lifesciences 913.85
Lupin 2118.25
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×